Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Andrew J. Armstrong
Based on 99 articles published since 2008
||||
Expertise Level
The expertise of Andrew J. Armstrong ranks in the
  • Top 0.014%
  • ... of 127,126 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 99 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Armstrong, Andrew   ·   Armstrong, A J   ·   Armstrong, Andrew J
Work Locations
Details
Most likely:    Duke University   Contact    
2017
  • Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. Electronic address: · Duke University Department of Biostatistics, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. · Wake Forest University, Winston-Salem, NC, USA. · University of Washington, Seattle, WA, USA. · Pubmed 28502694
  • Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke Cancer Institute, Durham, North Carolina. · Department of Biostatistics, Duke University, Durham, North Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. · Pubmed 27862097
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Duke Cancer Institute, Duke University, Durham, North Carolina. · Pubmed 28398272
  • Department of Medicine, Section of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL 35294, USA. Electronic address: · Duke Cancer Institute, Division of Medical Oncology, Department of Medicine, Durham, NC, USA. · Pubmed 28283283
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. Electronic address: · Duke University Medical Center, Durham, NC. · Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. · Duke University Medical Center, Durham, NC; Duke Cancer Institute, Durham, NC. · Pubmed 28126272
  • Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Duke Molecular Physiology Institute, Duke University, Durham, North Carolina. · Wake Forest School of Medicine, Winston Salem, North Carolina. · Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Pubmed 27601596
2016
  • Departments of Oncology and Urology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Divisions of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Masonic Cancer Center and Departments of Laboratory Medicine and Pathology and Urology, University of Minnesota, Minneapolis, MN, USA. · Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. · Pubmed 27184811
  • Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Pubmed 26700506
  • Division of Urology, Duke University Medical Center, DUMC Box 103861, Durham, NC 27710, USA. · Department of Medical Oncology, Duke University Medical Center, DUMC Box 103861, Durham, NC 27710, USA. Electronic address: · Pubmed 26614864
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. · Division of Urology, Department of Surgery, Duke University, Durham, NC, USA. · Duke Cancer Institute, Duke University, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Radiation Oncology, Duke University, Durham, NC, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Rutgers Cancer Institute of NJ, New Brunswick, NJ, USA. · Pubmed 26754260
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. · Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · Department of Medicine, Duke University, Durham, NC 27710, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA. · Pubmed 27713979
  • Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Genitourinary Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Oncology, Translational Research, Janssen Research and Development, Spring House, PA, USA. · Department of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA. · Department of Pathology, Duke University, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA. · Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA. · Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. · Pubmed 27409172
  • University of Alabama, Birmingham (UAB) School of Medicine, Birmingham, AL, USA. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Celgene Corporation, Summit, NJ, USA. · Cliniques universitaires Saint Luc, Brussels, Belgium. · Royal Melbourne Hospital, Parkville, Australia. · Duke Cancer Institute, Durham, NC, USA. · Yale University, New Haven, CT, USA. · Pubmed 26497922
  • Department of Medicine/Division of Medical Oncology, Durham, NC, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Durham, NC, USA. · Department of Pathology, Duke University and the Durham VA Medical Center, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Durham, NC, USA. · Department of Surgery/Division of Urology, Duke University and the Durham VA Medical Center, now at Cedars-Sinai Medical Center, Durham, NC, USA. · Pubmed 26458958
  • Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA. · Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA. · Department of Medicine, Pathology Division, Duke University Medical Center, Durham, North Carolina, USA. · Department of Medicine, Endocrinology Metabolism and Nutrition, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 27766686
2015
  • Duke Cancer Institute, Duke University, Durham, NC · Alliance Statistics and Data Center, Duke University, Durham, NC. · Pubmed 25667271
  • Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: · Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA; Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Pubmed 24612662
  • University of Alabama at Birmingham (UAB) School of Medicine, Birmingham, AL, USA. · Mount Sinai Tisch Cancer Institute, New York, NY, USA. · Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC, USA. · Pubmed 25046451
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Duke University, Durham, North Carolina. · Pubmed 26352773
  • Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Pubmed 26307134
  • DUMC Box 103861, Duke Cancer Institute, Divisions of Medical Oncology and Urology, Duke University, Durham, NC 27710, USA. Electronic address: · Pubmed 26028517
  • Presented by Andrew J. Armstrong, MD, ScM, Associate Professor of Medicine, Co-Director of Clinical Research Program, Duke Cancer Institute, Durham, North Carolina. · Pubmed 25995432
  • Department of Pharmacy, Duke University Hospital, Durham, NC, USA. · Division of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke Cancer Institute, Durham, NC, USA. · Pubmed 25777155
  • Duke Cancer Institute, Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke University Medical Center, Durham, NC. · University of California - San Francisco, San Francisco, CA. · Department of Radiology, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke University Medical Center, Durham, NC. Electronic address: · Pubmed 25708161
  • Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC. · Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC. · Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC; Department of Surgery, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Duke University Medical Center, Durham, NC. · Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC. Electronic address: · Pubmed 25595577
2014
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, DUMC Box 102002, Durham, NC 27710, USA. Electronic address: · Pubmed 24054873
  • Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA · Pubmed 24859991
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC. Electronic address: · Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. · Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden. · Department of Medicine, University of Chicago, Chicago, IL. · Active Biotech AB, Lund, Sweden. · Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; Department of Clinical Sciences, Lund University, Malmö, Sweden; EXINI Diagnostics AB, Lund, Sweden. · Roswell Park Cancer Institute Genitourinary Program, Buffalo, NY. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 25240761
  • University of Alabama, Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, McMaster University, Hamilton, Canada. · Duke University, Durham, NC. · University of Sydney, Sydney, Australia. · Princess Margaret Cancer Centre, Toronto, Canada. · Pfizer Inc, New Jersey, NJ; ICON Clinical Research Inc, San Diego, CA. · Pfizer Inc, New Jersey, NJ. · Pfizer Inc, New Jersey, NJ; Aragon Pharmaceuticals, San Diego, CA. · Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. · Pubmed 24806399
  • Department of Medicine, Division of Hematology-Oncology, University of Alabama, Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL, USA. · Department of Biostatistics, McMaster University, Hamilton, ON, Canada. · Department of Medicine, Division of Hematology-Oncology, Duke Prostate Center, Durham, NC, USA. · Department of Medicine, Division of Hematology-Oncology, Mt Sinai Tisch Cancer Institute, New York, NY, USA. · Ascenta Therapeutics, Malvern, PA, USA. · Pfizer Inc., Madison, NJ, USA. · ICON Clinical Research Inc., San Diego, CA, USA. · Seragon Pharmaceuticals, San Diego, CA, USA. · Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital and the Harvard Medical School, Boston, MA, USA. · Pubmed 24298897
  • Duke Cancer Institute, Duke University, Durham, North Carolina. · Pubmed 24892256
2013
  • Duke Cancer Institute, Durham, North Carolina. · Pubmed 24896544
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham NC; Department of Medicine, Division of Medical Oncology, Duke University, Durham NC; Department of Surgery, Division of Urology, Duke University, Durham NC; Duke University Medical Center, Duke University, Durham NC. Electronic address: · Pubmed 23830964
2012
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC 27710, USA. · Pubmed 22099611
  • Duke Cancer Institute and Duke Prostate Center, Duke University Medical Center, Durham, NC, USA. · Pubmed 22452892
  • Duke Cancer Institute, Durham, North Carolina, USA. · Pubmed 22393801
2011
  • Divisions of Medical Oncology and Urology, Duke Cancer Institute and the Duke Prostate Center, Durham, North Carolina, USA. · Pubmed 22407145
  • Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 21665936
  • Duke Cancer Institute, Department of Medicine, Duke Prostate Center, Duke University, Durham, NC 27710, USA. · Pubmed 21383677
2010
  • Duke Prostate Center, Durham, NC, USA. · Pubmed 20066005
  • Division of Medical Oncology, Department of Medicine, DUMC, Duke Comprehensive Cancer Center and the Duke Prostate Center, Durham, NC 27715, USA. · Pubmed 20005697
  • Duke Comprehensive Cancer Center and Duke Prostate Center, Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina 27710, USA. · Pubmed 20501622
  • Department of Medicine, Division of Medical Oncology, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina 102002, USA. · Pubmed 20008841
2009
  • Department of Medicine and Surgery, Duke Comprehensive Cancer Center, Durham, NC 27710, USA. · Pubmed 19684076
  • Duke Comprehensive Cancer Center, Duke University, Durham, NC 27705, USA. · Pubmed 18574490
2008
  • Division of Medical Oncology, Department of Medicine, Duke Comprehensive Cancer Center, DUMC, Durham, NC 27705, USA. · Pubmed 18593623
  • Duke Prostate Center, 2424 Erwin Road, Durham, NC 27705, USA. · Pubmed 18829508
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy; Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Roberto Pili, Indiana University School of Medicine, Indianapolis, IN; Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia; Robert Huddart, Royal Marsden Hospital, Sutton; Nicholas James, Queen Elizabeth Hospital, Birmingham; Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia; Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine; Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia; Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers; Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France; Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania; Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece; Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium; Martin Bögemann, Universitätsklinikum Münster, Münster, Germany; Thomas Hutson, Texas Oncology, Dallas, TX; Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland; Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain; Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil; Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden; and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy; Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Roberto Pili, Indiana University School of Medicine, Indianapolis, IN; Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia; Robert Huddart, Royal Marsden Hospital, Sutton; Nicholas James, Queen Elizabeth Hospital, Birmingham; Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia; Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine; Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia; Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers; Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France; Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania; Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece; Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium; Martin Bögemann, Universitätsklinikum Münster, Münster, Germany; Thomas Hutson, Texas Oncology, Dallas, TX; Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland; Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain; Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil; Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden; and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Pubmed 27298414
  • David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 26811535
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • a Duke Cancer Institute, Duke University Medical Center , Durham , NC , USA . · Pubmed 26079252
  • Duke Cancer Institute, Duke University Medical Center, Division of Medical Oncology, Department of Medicine , DUMC 3841, Durham, NC 27710 , USA. · Pubmed 25534660
2014
  • From the aDepartment of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, and Department of Medicine, and bDepartment of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina. · Pubmed 24812138
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, NC, 27710, USA. · Pubmed 24414193
  • Division of Urology and the Duke Prostate Center, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 25041422
2013
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, North Carolina 27710, USA. · Pubmed 23456430
  • Duke Cancer Institute and the Duke Prostate Center, Durham, NC 27710, USA. · Pubmed 23337754
  • Duke Cancer Institute and the Duke Prostate Center, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, DUMCBox 102002, Durham, NC 27710, USA. · Pubmed 23322116
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Authors' Affiliations: Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, North Carolina; University Hospital of Uppsala, Uppsala, Sweden; University of Chicago, Chicago, Illinois; University of Pittsburgh, Pittsburgh, Pennsylvania; Peachtree Hematology Oncology Consultants, Atlanta, Georgia; Kaiser Permanente Medical Group, San Diego, California; Sahlgrenska University Hospital, Gothenburg, Sweden; Urologic Consultants of SE PA, Bala Cynwyd, Pennsylvania; Active Biotech AB, Lund, Sweden; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore Maryland; Roswell Park Cancer Institute, Buffalo, New York. · Pubmed 24255071
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, United States; Department of Medicine, Duke University, Durham, NC, United States; Center for RNA Biology, Duke University, Durham, NC, United States. · Pubmed 23845299
  • Duke University Medical Center, Durham, NC 27710, USA. Electronic address: · Pubmed 22305627
2012
  • Division of Urology, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 22088334
2008
  • Duke Prostate Center, Durham, North Carolina, USA. · Pubmed 18382240
  • Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. · Pubmed 18303482
Probable:    Miscellaneous institutions in Research Triangle      
2016
  • Department of Medicine/Division of Medical Oncology, Durham, NC, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Durham, NC, USA. · Department of Pathology, Duke University and the Durham VA Medical Center, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Durham, NC, USA. · Department of Surgery/Division of Urology, Duke University and the Durham VA Medical Center, now at Cedars-Sinai Medical Center, Durham, NC, USA. · Pubmed 26458958
Probable:    Mayo Clinic Rochester      
2014
  • Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA · Pubmed 24859991
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 99 total) written by Andrew J. Armstrong about Prostatic Neoplasms:

  • Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer. 2017
  • Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. 2017
  • Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study. 2017
  • Prognostic and predictive biomarkers in metastatic castration-resistant prostate cancer. 2017
  • Drug development in prostate cancer: time to embrace RECIST? 2017
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. 2017
  • Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer. 2017
  • Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer. 2017
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 2016
  • Prostate Cancer, Version 1.2016. 2016
Show List of Full Article Records
Google Searches

Learn more about Andrew J. Armstrong using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Duke University
Miscellaneous institutions in Research Triangle
Mayo Clinic Rochester
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Duke University
2017
  • Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. Electronic address: · Duke University Department of Biostatistics, USA. · Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA. · Wake Forest University, Winston-Salem, NC, USA. · University of Washington, Seattle, WA, USA. · Pubmed 28502694
  • Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke Cancer Institute, Durham, North Carolina. · Department of Biostatistics, Duke University, Durham, North Carolina. · Department of Medicine, University of Chicago, Chicago, Illinois. · Pubmed 27862097
  • Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. Electronic address: · Duke Cancer Institute, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Institut Gustave-Roussy, Villejuif, France. · San Camillo and Forlanini Hospitals, Rome, Italy. · University of Washington, Seattle Cancer Care Alliance, Seattle, WA, USA. · Rigshospitalet, Copenhagen, Denmark. · UC Davis Cancer Center, Sacramento, CA, USA. · Asan Medical Center, Seoul, Korea. · Nippon Medical School, Tokyo, Japan. · Charité Universitätsmedizin, Berlin, Germany. · University of Montreal Hospital Center, Montreal, QC, Canada. · Skåne University Hospital, Malmö, Sweden. · Aarhus University Hospital, Aarhus, Denmark. · Radboud University Medical Center, Nijmegen, Netherlands. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Medivation, San Francisco, CA, USA. · Astellas Pharma Europe, Leiden, The Netherlands. · Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27477525
  • Duke Cancer Institute, Duke University, Durham, North Carolina. · Pubmed 28398272
  • Department of Medicine, Section of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL 35294, USA. Electronic address: · Duke Cancer Institute, Division of Medical Oncology, Department of Medicine, Durham, NC, USA. · Pubmed 28283283
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. Electronic address: · Duke University Medical Center, Durham, NC. · Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. · Duke University Medical Center, Durham, NC; Duke Cancer Institute, Durham, NC. · Pubmed 28126272
  • Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Duke Molecular Physiology Institute, Duke University, Durham, North Carolina. · Wake Forest School of Medicine, Winston Salem, North Carolina. · Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Pubmed 27601596
2016
  • Departments of Oncology and Urology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Divisions of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Masonic Cancer Center and Departments of Laboratory Medicine and Pathology and Urology, University of Minnesota, Minneapolis, MN, USA. · Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. · Pubmed 27184811
  • Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center DUMC 103861, Durham, NC, 27710, USA. · Pubmed 26700506
  • Division of Urology, Duke University Medical Center, DUMC Box 103861, Durham, NC 27710, USA. · Department of Medical Oncology, Duke University Medical Center, DUMC Box 103861, Durham, NC 27710, USA. Electronic address: · Pubmed 26614864
  • Department of Urology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address: · Medical Oncology Division, University of Washington/Seattle Cancer Care Alliance, Seattle, WA, USA. · Department of Urology, Medical University of South Carolina, Charleston, SC, USA. · Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA. · Department of Surgery, University of Montreal Health Center, Montreal, Canada. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, Denmark. · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Urology, Asan Medical Center, Seoul, South Korea. · Department of Urology, Nippon Medical School Hospital, Tokyo, Japan. · Division of Medical Oncology and Urology, Duke Cancer Institute, Durham, NC, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave-Roussy, Villejuif, France. · Drug Development Unit, Institute of Cancer Research, Royal Marsden Hospital, London, UK. · Department of Early Clinical Development, Medivation, Inc., San Francisco, CA, USA. · Department of Medical Affairs, Medivation, Inc., San Francisco, CA, USA. · Department of Biostatistics, Medivation, Inc., San Francisco, CA, USA. · Astellas Pharma, Inc., Northbrook, IL, USA. · Department of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 27006332
  • Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA. · Division of Urology, Department of Surgery, Duke University, Durham, NC, USA. · Duke Cancer Institute, Duke University, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. · Department of Radiation Oncology, Duke University, Durham, NC, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Rutgers Cancer Institute of NJ, New Brunswick, NJ, USA. · Pubmed 26754260
  • Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland Division of Oncology, Portland VA Medical Center, Portland, USA · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Divisions of Medical Oncology and Urology, Duke University Medical Center and the Duke Cancer Institute, Durham. · Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. · Copenhagen Prostate Cancer Center, Rigshospitalet, University of Copenhagen, København, Denmark. · Department of Medical Oncology, University of Colorado Cancer Center, Aurora. · Medivation, Inc., San Francisco, USA. · Astellas Pharma Global Development, Inc., Leiden, The Netherlands. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland. · Pubmed 26578735
  • NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. · Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA. · Department of Medicine, Duke University, Durham, NC 27710, USA. · NSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA and Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA and Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA and Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA. · Pubmed 27713979
  • Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Genitourinary Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Oncology, Translational Research, Janssen Research and Development, Spring House, PA, USA. · Department of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA. · Department of Pathology, Duke University, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USA. · Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA. · Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. · Pubmed 27409172
  • University of Alabama, Birmingham (UAB) School of Medicine, Birmingham, AL, USA. Electronic address: · McMaster University, Hamilton, Ontario, Canada. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Celgene Corporation, Summit, NJ, USA. · Cliniques universitaires Saint Luc, Brussels, Belgium. · Royal Melbourne Hospital, Parkville, Australia. · Duke Cancer Institute, Durham, NC, USA. · Yale University, New Haven, CT, USA. · Pubmed 26497922
  • Department of Medicine/Division of Medical Oncology, Durham, NC, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Durham, NC, USA. · Department of Pathology, Duke University and the Durham VA Medical Center, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Durham, NC, USA. · Department of Surgery/Division of Urology, Duke University and the Durham VA Medical Center, now at Cedars-Sinai Medical Center, Durham, NC, USA. · Pubmed 26458958
  • Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA. · Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA. · Department of Medicine, Pathology Division, Duke University Medical Center, Durham, North Carolina, USA. · Department of Medicine, Endocrinology Metabolism and Nutrition, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 27766686
2015
  • Duke Cancer Institute, Duke University, Durham, NC · Alliance Statistics and Data Center, Duke University, Durham, NC. · Pubmed 25667271
  • Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: · Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA; Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Pubmed 24612662
  • University of Alabama at Birmingham (UAB) School of Medicine, Birmingham, AL, USA. · Mount Sinai Tisch Cancer Institute, New York, NY, USA. · Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC, USA. · Pubmed 25046451
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Duke University, Durham, North Carolina. · Pubmed 26352773
  • Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina. · Pubmed 26307134
  • DUMC Box 103861, Duke Cancer Institute, Divisions of Medical Oncology and Urology, Duke University, Durham, NC 27710, USA. Electronic address: · Pubmed 26028517
  • Presented by Andrew J. Armstrong, MD, ScM, Associate Professor of Medicine, Co-Director of Clinical Research Program, Duke Cancer Institute, Durham, North Carolina. · Pubmed 25995432
  • Department of Pharmacy, Duke University Hospital, Durham, NC, USA. · Division of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke Cancer Institute, Durham, NC, USA. · Pubmed 25777155
  • Duke Cancer Institute, Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke University Medical Center, Durham, NC. · University of California - San Francisco, San Francisco, CA. · Department of Radiology, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery, Duke University Medical Center, Durham, NC. Electronic address: · Pubmed 25708161
  • Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC. · Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Duke University Medical Center, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC. · Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC; Department of Surgery, Duke University Medical Center, Durham, NC. · Duke Cancer Institute, Duke University Medical Center, Durham, NC. · Department of Medicine, Duke University Medical Center, Durham, NC; Duke Cancer Institute, Duke University Medical Center, Durham, NC. Electronic address: · Pubmed 25595577
2014
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, DUMC Box 102002, Durham, NC 27710, USA. Electronic address: · Pubmed 24054873
  • Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA · Pubmed 24859991
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC. Electronic address: · Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. · Department of Urology, Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden. · Department of Medicine, University of Chicago, Chicago, IL. · Active Biotech AB, Lund, Sweden. · Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; Department of Clinical Sciences, Lund University, Malmö, Sweden; EXINI Diagnostics AB, Lund, Sweden. · Roswell Park Cancer Institute Genitourinary Program, Buffalo, NY. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 25240761
  • University of Alabama, Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. Electronic address: · Ontario Clinical Oncology Group, McMaster University, Hamilton, Canada. · Duke University, Durham, NC. · University of Sydney, Sydney, Australia. · Princess Margaret Cancer Centre, Toronto, Canada. · Pfizer Inc, New Jersey, NJ; ICON Clinical Research Inc, San Diego, CA. · Pfizer Inc, New Jersey, NJ. · Pfizer Inc, New Jersey, NJ; Aragon Pharmaceuticals, San Diego, CA. · Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. · Pubmed 24806399
  • Department of Medicine, Division of Hematology-Oncology, University of Alabama, Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL, USA. · Department of Biostatistics, McMaster University, Hamilton, ON, Canada. · Department of Medicine, Division of Hematology-Oncology, Duke Prostate Center, Durham, NC, USA. · Department of Medicine, Division of Hematology-Oncology, Mt Sinai Tisch Cancer Institute, New York, NY, USA. · Ascenta Therapeutics, Malvern, PA, USA. · Pfizer Inc., Madison, NJ, USA. · ICON Clinical Research Inc., San Diego, CA, USA. · Seragon Pharmaceuticals, San Diego, CA, USA. · Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital and the Harvard Medical School, Boston, MA, USA. · Pubmed 24298897
  • Duke Cancer Institute, Duke University, Durham, North Carolina. · Pubmed 24892256
2013
  • Duke Cancer Institute, Durham, North Carolina. · Pubmed 24896544
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham NC; Department of Medicine, Division of Medical Oncology, Duke University, Durham NC; Department of Surgery, Division of Urology, Duke University, Durham NC; Duke University Medical Center, Duke University, Durham NC. Electronic address: · Pubmed 23830964
2012
  • Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC 27710, USA. · Pubmed 22099611
  • Duke Cancer Institute and Duke Prostate Center, Duke University Medical Center, Durham, NC, USA. · Pubmed 22452892
  • Duke Cancer Institute, Durham, North Carolina, USA. · Pubmed 22393801
2011
  • Divisions of Medical Oncology and Urology, Duke Cancer Institute and the Duke Prostate Center, Durham, North Carolina, USA. · Pubmed 22407145
  • Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 21665936
  • Duke Cancer Institute, Department of Medicine, Duke Prostate Center, Duke University, Durham, NC 27710, USA. · Pubmed 21383677
2010
  • Duke Prostate Center, Durham, NC, USA. · Pubmed 20066005
  • Division of Medical Oncology, Department of Medicine, DUMC, Duke Comprehensive Cancer Center and the Duke Prostate Center, Durham, NC 27715, USA. · Pubmed 20005697
  • Duke Comprehensive Cancer Center and Duke Prostate Center, Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina 27710, USA. · Pubmed 20501622
  • Department of Medicine, Division of Medical Oncology, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina 102002, USA. · Pubmed 20008841
2009
  • Department of Medicine and Surgery, Duke Comprehensive Cancer Center, Durham, NC 27710, USA. · Pubmed 19684076
  • Duke Comprehensive Cancer Center, Duke University, Durham, NC 27705, USA. · Pubmed 18574490
2008
  • Division of Medical Oncology, Department of Medicine, Duke Comprehensive Cancer Center, DUMC, Durham, NC 27705, USA. · Pubmed 18593623
  • Duke Prostate Center, 2424 Erwin Road, Durham, NC 27705, USA. · Pubmed 18829508
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy; Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Roberto Pili, Indiana University School of Medicine, Indianapolis, IN; Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia; Robert Huddart, Royal Marsden Hospital, Sutton; Nicholas James, Queen Elizabeth Hospital, Birmingham; Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia; Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine; Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia; Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers; Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France; Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania; Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece; Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium; Martin Bögemann, Universitätsklinikum Münster, Münster, Germany; Thomas Hutson, Texas Oncology, Dallas, TX; Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland; Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain; Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil; Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden; and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Cora Sternberg, San Camillo Forlanini Hospitals, Rome, Italy; Andrew Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Roberto Pili, Indiana University School of Medicine, Indianapolis, IN; Siobhan Ng, St John of God Medical Centre, Subiaco, Western Australia, Australia; Robert Huddart, Royal Marsden Hospital, Sutton; Nicholas James, Queen Elizabeth Hospital, Birmingham; Simon Chowdhury, Guy's Hospital and Sarah Cannon Research UK, London, United Kingdom; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Denis Khvorostenko, Leningrad Regional Oncology Dispensary, St Petersburg, Russia; Olexiy Lyulko, Zaporizhzhya Regional Clinical Hospital, Zaporizhzhya, Ukraine; Arija Brize, Riga Eastern Clinical University Hospital, Riga, Latvia; Nicholas Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Rémy Delva, Centre Régional de Lutte Contre le Cancer Paul Papin, Angers; Jean-Christophe Pouget and Frédérique Baton, Ipsen Innovation, Les Ulis, France; Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania; Anastasios Thanos, Agios Savas Anticancer Oncology Hospital of Athens, Athens, Greece; Patrick Werbrouck, Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium; Martin Bögemann, Universitätsklinikum Münster, Münster, Germany; Thomas Hutson, Texas Oncology, Dallas, TX; Piotr Milecki, Poznan University of Medical Sciences, Poznan, Poland; Enrique Gallardo, Corporació Sanitaria Parc Taulí, Sabadell, Spain; Gilberto Schwartsmann, Hospital De Clinicas De Porto Alegre, Porto Alegre, Brazil; Thore Nederman and Helen Tuvesson, Active Biotech, Lund, Sweden; and Michael Carducci, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD. · Pubmed 27298414
  • David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA. · Pubmed 26811535
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • a Duke Cancer Institute, Duke University Medical Center , Durham , NC , USA . · Pubmed 26079252
  • Duke Cancer Institute, Duke University Medical Center, Division of Medical Oncology, Department of Medicine , DUMC 3841, Durham, NC 27710 , USA. · Pubmed 25534660
2014
  • From the aDepartment of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, and Department of Medicine, and bDepartment of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina. · Pubmed 24812138
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, NC, 27710, USA. · Pubmed 24414193
  • Division of Urology and the Duke Prostate Center, Duke University Medical Center, Durham, North Carolina, USA. · Pubmed 25041422
2013
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, DUMC Box 102002, Durham, North Carolina 27710, USA. · Pubmed 23456430
  • Duke Cancer Institute and the Duke Prostate Center, Durham, NC 27710, USA. · Pubmed 23337754
  • Duke Cancer Institute and the Duke Prostate Center, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, DUMCBox 102002, Durham, NC 27710, USA. · Pubmed 23322116
  • Affiliations of authors: Department of Biostatistics and Bioinformatics, (SH, C-YL, EK), and Alliance Statistics and Data Center (SH), Duke University, Durham, NC; Departments of Medicine and Urology, University of California-San Francisco, San Francisco, CA (EJS); Division of Medical Oncology, Duke Prostate Center and the Duke Cancer Institute, Durham, NC (AJA); Departments of Medical Oncology and Urology, Yale University Cancer Center, New Haven, CT (DP); Department of Medical Oncology, San Camillo and Forlanini Hospital, Rome, Italy (CNS); Sanofi, Malvern, PA (LS); Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France (SO); Department of Clinical Studies, Royal Marsden Hospital and Institute of Cancer Research, Surrey, United Kingdom (JdB); Urology Department, Tulane Cancer Center, New Orleans, LA (OS). · Pubmed 24136890
  • Susan Halabi, Andrew J. Armstrong, Ellen Kaplan, Chen-Yen Lin, and Nicole C. Solomon, Duke University, Durham, NC; Oliver Sartor, Tulane University, New Orleans, LA; Johann de Bono, Royal Marsden Hospital, Sutton, United Kingdom; and Eric J. Small, University of California at San Francisco, San Francisco, CA. · Pubmed 24101043
  • Authors' Affiliations: Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, North Carolina; University Hospital of Uppsala, Uppsala, Sweden; University of Chicago, Chicago, Illinois; University of Pittsburgh, Pittsburgh, Pennsylvania; Peachtree Hematology Oncology Consultants, Atlanta, Georgia; Kaiser Permanente Medical Group, San Diego, California; Sahlgrenska University Hospital, Gothenburg, Sweden; Urologic Consultants of SE PA, Bala Cynwyd, Pennsylvania; Active Biotech AB, Lund, Sweden; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore Maryland; Roswell Park Cancer Institute, Buffalo, New York. · Pubmed 24255071
  • Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, United States; Department of Medicine, Duke University, Durham, NC, United States; Center for RNA Biology, Duke University, Durham, NC, United States. · Pubmed 23845299
  • Duke University Medical Center, Durham, NC 27710, USA. Electronic address: · Pubmed 22305627
2012
  • Division of Urology, Duke University Medical Center, Durham, North Carolina 27710, USA. · Pubmed 22088334
2008
  • Duke Prostate Center, Durham, North Carolina, USA. · Pubmed 18382240
  • Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. · Pubmed 18303482
Miscellaneous institutions in Research Triangle
2016
  • Department of Medicine/Division of Medical Oncology, Durham, NC, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Department of Biostatistics and Bioinformatics, Durham, NC, USA. · Department of Pathology, Duke University and the Durham VA Medical Center, Durham, NC, USA. · Department of Molecular Genetics and Microbiology, Durham, NC, USA. · Department of Surgery/Division of Urology, Duke University and the Durham VA Medical Center, now at Cedars-Sinai Medical Center, Durham, NC, USA. · Pubmed 26458958
Unspecified
2015
  • Duke Cancer Institute in Durham, NC. · Duke Raleigh Hospital in Raleigh, NC. · Duke Raleigh Hospital and the Duke Cancer Institute. · Wake Forest Baptist Health in Winston-Salem, NC. · Duke Cancer Institute. · Pubmed 26000580
2014
Mayo Clinic Rochester
2014
  • Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA. · Departments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USADepartments of Molecular Genetics and MedicineDuke University, 213 Research Dr, 0045 CARL Building, Durham, North Carolina 27710, USADepartment of MedicineDuke Cancer Institute, Duke University, Durham, North Carolina, USAMasonic Cancer CenterUniversity of Minnesota Masonic Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USADepartment of Laboratory Medicine and PathologyUniversity of Minnesota, Minneapolis, Minnesota, USA · Pubmed 24859991
75 Other Locations Show
Yearly article counts 0816141418117425
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.